WPWM
WST icon

Western Pacific Wealth Management’s West Pharmaceutical WST Stock Holding History

Western Pacific Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-166
Closed -$36.3K – 205
2025
Q2 		$36.3K Hold
166
– – 0.03% 147
2025
Q1 		$37.2K Sell
166
-93
-36% -$25.6K 0.03% 138
2024
Q4 		$84.8K Buy
+259
New +$81.5K 0.07% 114

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Western Pacific Wealth Management's WST Position: Q3 2025 in Review

Western Pacific Wealth Management sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 166 shares — an estimated $36.3K sold.

Western Pacific Wealth Management first reported a position in WST in Q4 2024 and held it in 3 quarters. The position peaked at $84.8K in Q4 2024. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Western Pacific Wealth Management reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Western Pacific Wealth Management sold 166 West Pharmaceutical shares in Q3 2025, an estimated $36.3K.
  • Western Pacific Wealth Management first reported a position in West Pharmaceutical in Q4 2024 and held it in 3 quarters.
  • Western Pacific Wealth Management's West Pharmaceutical position peaked at $84.8K in Q4 2024.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Western Pacific Wealth Management's 13F filing for Q3 2025, filed 21 Oct 2025.